Healthcare

Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...

This research service provides insight into the top therapeutics sold at a Kenyan private outpatient pharmacy, located in one of Nairobis largest private hospitals. This service gives a brief overview of the healthcare structure in Kenya. Key therapeutic segments analyzed include anti-infectives, cardiovascular, and diabetes therapeutic segments. S...

This issue of Vital Signs published June 30, 2013, provides a global overview of market trends and expected growth of the Point-of-care Testing (POCT) market.

This issue of Vital Signs, released on June 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

The world is seeing an outburst of disease-based regional and national biobanks for clinical research; as a result, good storage practices and standard operating procedures (SOPs) play a vital role in preserving decade-old samples. Complaint storage, sample shipment and data management procedures should be carefully considered to enable the formula...

This issue of Vital Signs, released on May 28, 2013, provides an insight in to medical image management. Additionally, a company spotlight is provided for Cloud-Based Image Exchange. Image exchange provides a good case in point of the recent evolution of cloud-based applications in imaging. Image exchange is only a small subset of the larger appl...

Picture archiving and communication systems, commonly known as PACS, have only recently gained ground in the Malaysian healthcare delivery system. Given the comparatively small installed base in this country and the technologys need to be updated every 3 to 5 years, the Malaysian market presents significant opportunities for PACS vendors. This rese...

This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients ad...

This issue of Vital Signs, released on April 30, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.